In contrast, however, β2AR stimulation of the bone metastatic MDA-231 clone, which is derived from MDA-MB-231 cells following in vivo selection of bone osteotropic cells [31], reduced tumor growth when cells were implanted subcutaneously. The gene discussed is ADRB2; the disease is neoplasm.